DEPOMED INC 4

4 · DEPOMED INC · Filed Jun 15, 2017

Form 4

Period: 2017-06-13

Senior VP, BD

Transactions

Sale
Common Stock
2017-06-13$9.60/sh−19,816$190,234→ 0 total
Sale
Common Stock
2017-06-13$9.53/sh−160,820$1,531,971→ 0 total
Exercise/Conversion
Common Stock
2017-06-13−19,320→ 0 total
Exercise: $7.12Exp: 2021-01-14→ Common Stock (19,320 underlying)
Sale
Common Stock
2017-06-13$9.59/sh−21,751$208,527→ 19,816 total
Exercise/Conversion
Common Stock
2017-06-13$6.11/sh+43,000$262,730→ 107,320 total
Exercise/Conversion
Common Stock
2017-06-13$6.08/sh+45,000$273,600→ 64,320 total
Exercise/Conversion
Common Stock
2017-06-13$6.77/sh+53,500$362,195→ 160,820 total
Exercise/Conversion
Common Stock
2017-06-13−43,000→ 0 total
Exercise: $6.11Exp: 2022-01-12→ Common Stock (43,000 underlying)
Exercise/Conversion
Common Stock
2017-06-13−53,500→ 0 total
Exercise: $6.77Exp: 2023-02-07→ Common Stock (53,500 underlying)
Exercise/Conversion
Common Stock
2017-06-13−45,000→ 0 total
Exercise: $6.08Exp: 2021-09-01→ Common Stock (45,000 underlying)
Exercise/Conversion
Common Stock
2017-06-13$7.12/sh+19,320$137,558→ 19,320 total

Footnotes (6)

[F1]Amount does not include any unvested restricted stock previously reported on Form 4 by the reporting person.
[F2]The price reported is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares at each price within the range set forth in this footnote.
[F3]19,320 stock options were granted on January 14, 2011 and were exercisable in 48 equal monthly installments.
[F4]45,000 stock options were granted on September 1, 2011 and were exercisable in 48 equal monthly installments.
[F5]43,000 stock options were granted on January 12, 2012 and were exercisable in 48 equal monthly installments.
[F6]53,500 stock options were granted on February 7, 2013 and were exercisable in 48 equal monthly installments.

Documents

1 file